Neosporin Ointment 14.2g
₦18,000.00
Lynxiclav 625 mg is a combination antibiotic that features amoxicillin and clavulanate potassium. This formulation is designed to effectively treat various bacterial infections, particularly those caused by resistant strains.
Key Features:
- Active Ingredients:
- Amoxicillin (500 mg): A broad-spectrum penicillin antibiotic that inhibits bacterial cell wall synthesis.
- Clavulanate Potassium (125 mg): A beta-lactamase inhibitor that protects amoxicillin from degradation by certain bacteria, enhancing its antibacterial effectiveness.
- Indications:
- Commonly used to treat:
- Respiratory tract infections (e.g., pneumonia, bronchitis)
- Urinary tract infections
- Skin and soft tissue infections
- Dental infections
- Sinusitis
- Commonly used to treat:
- Dosage Form:
- Available as tablets for convenient oral administration.
Usage:
- Dosage:
- The recommended dosage should be prescribed by a healthcare provider. Typically, adults may take one tablet every 12 hours, depending on the severity of the infection.
- Administration:
- Take the tablet with a full glass of water. It is advisable to take it with food to minimize gastrointestinal side effects.
Precautions:
- Allergies:
- Inform your healthcare provider of any known allergies to penicillin or other beta-lactam antibiotics.
- Side Effects:
- Possible side effects may include nausea, diarrhea, rash, and allergic reactions. Report any severe or unusual side effects to your healthcare provider immediately.
- Interactions:
- Discuss any other medications you are taking with your healthcare provider to avoid potential interactions, especially with anticoagulants and other antibiotics.
Storage:
- Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
- Very secured payment methods
- Shipping will be calculated on checkout
- Please note that price may increase due to exchange rate, ensure updated price before making payment
Dispensing supervised byPharm. Tope Kareem, B.PharmPCN Reg. 023669
Last updated 28 August 2026How we write and check this informationPCN Premises Licence LAG20247B39C9





Reviews
There are no reviews yet.